These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259 [TBL] [Abstract][Full Text] [Related]
3. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders. Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845 [TBL] [Abstract][Full Text] [Related]
4. Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). Fujihara K; Itoyama Y; Yu F; Kubo C; Goto I J Neurol Sci; 1991 Sep; 105(1):99-107. PubMed ID: 1795176 [TBL] [Abstract][Full Text] [Related]
5. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814 [TBL] [Abstract][Full Text] [Related]
6. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847 [TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibodies against HTLV-I in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients and asymptomatic carriers. Minagawa H; Yoshida T; Itoyama Y; Mora CA; Albert P; Mori R Neurology; 1992 Nov; 42(11):2210-2. PubMed ID: 1436540 [TBL] [Abstract][Full Text] [Related]
8. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders. Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872 [TBL] [Abstract][Full Text] [Related]
10. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis. Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163 [TBL] [Abstract][Full Text] [Related]
11. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677 [TBL] [Abstract][Full Text] [Related]
12. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load. de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF; J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636 [TBL] [Abstract][Full Text] [Related]
13. Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers. Medina F; Quintremil S; Alberti C; Godoy F; Pando ME; Bustamante A; Barriga A; Cartier L; Puente J; Tanaka Y; Valenzuela MA; Ramírez E J Med Virol; 2016 Mar; 88(3):521-31. PubMed ID: 26241614 [TBL] [Abstract][Full Text] [Related]
14. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. Jeffery KJ; Siddiqui AA; Bunce M; Lloyd AL; Vine AM; Witkover AD; Izumo S; Usuku K; Welsh KI; Osame M; Bangham CR J Immunol; 2000 Dec; 165(12):7278-84. PubMed ID: 11120862 [TBL] [Abstract][Full Text] [Related]
15. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load. Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240 [TBL] [Abstract][Full Text] [Related]
16. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers. Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801 [TBL] [Abstract][Full Text] [Related]
17. Human T-cell lymphotropic virus type-I (HTLV-I)-associated myelopathy/tropical spastic paraparesis with acute type of adult T-cell leukemia. Furukawa Y; Okadome T; Tara M; Niina K; Izumo S; Osame M Intern Med; 1995 Nov; 34(11):1130-3. PubMed ID: 8774979 [TBL] [Abstract][Full Text] [Related]